345 related articles for article (PubMed ID: 34884878)
1. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal.
Espejo-Cruz ML; González-Rubio S; Zamora-Olaya J; Amado-Torres V; Alejandre R; Sánchez-Frías M; Ciria R; De la Mata M; Rodríguez-Perálvarez M; Ferrín G
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884878
[TBL] [Abstract][Full Text] [Related]
2. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
[TBL] [Abstract][Full Text] [Related]
3. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
Chen J; Cao SW; Cai Z; Zheng L; Wang Q
Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Performance of Circulating Tumor Cells for Predicting of Hepatocellular Carcinoma in Hepatitis C Virus-High Risk Patients: Role of Liquid Biopsy.
El-Mezayen HA; El -Kassas M; El-Taweel FM; Metwally FM; Ghonaim NA; Zahran RF
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2541-2549. PubMed ID: 35901363
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
[TBL] [Abstract][Full Text] [Related]
8. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik MR; Sagar PR; Shaik NA; Randhawa N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications.
Zhang Q; Rong Y; Yi K; Huang L; Chen M; Wang F
Theranostics; 2020; 10(26):12060-12071. PubMed ID: 33204329
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies for hepatocellular carcinoma.
Su YH; Kim AK; Jain S
Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
[TBL] [Abstract][Full Text] [Related]
13. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
[TBL] [Abstract][Full Text] [Related]
14. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma.
Li X; Wang H; Li T; Wang L; Wu X; Liu J; Xu Y; Wei W
Curr Probl Cancer; 2020 Apr; 44(2):100516. PubMed ID: 31836136
[TBL] [Abstract][Full Text] [Related]
16. Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review.
Chen VL; Xu D; Wicha MS; Lok AS; Parikh ND
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2879-2902.e9. PubMed ID: 32289533
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
[TBL] [Abstract][Full Text] [Related]
18. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.
Li J; Shi L; Zhang X; Sun B; Yang Y; Ge N; Liu H; Yang X; Chen L; Qian H; Wu M; Yin Z
Oncotarget; 2016 Jan; 7(3):2646-59. PubMed ID: 26544731
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.
Yin CQ; Yuan CH; Qu Z; Guan Q; Chen H; Wang FB
Dis Markers; 2016; 2016():1427849. PubMed ID: 27403030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
